4613347803

Figurę 2. Decomplementation mcreases NK celi availabihty without affecting their effector function. B16gp33-bearing mice were treated or not with CVF. On day 9 following treatment, spleen and tumor were harvested. A, Percentage of NK cells among CD45⁺ cells. Mean ± SEM are shown (n=9). ***P < 0.001. B, NK degranulation assay in YAC-1 co-cultures (101 Effector-target ratio) with or without PMA-ionomycin. Data are the mean ± SEM of three independent experiments (n=9).